Sutro Biopharma, Inc. (STRO)
16.00
+0.29
(+1.85%)
USD |
NASDAQ |
Sep 25, 16:00
16.00
0.00 (0.00%)
After-Hours: 17:17
Sutro Biopharma Cash and Short Term Investments (Quarterly) : 164.35M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 164.35M |
| March 31, 2026 | 202.56M |
| December 31, 2025 | 141.43M |
| September 30, 2025 | 167.59M |
| June 30, 2025 | 205.13M |
| March 31, 2025 | 248.97M |
| December 31, 2024 | 316.90M |
| September 30, 2024 | 388.25M |
| June 30, 2024 | 425.99M |
| March 31, 2024 | 313.22M |
| December 31, 2023 | 375.62M |
| September 30, 2023 | 355.15M |
| June 30, 2023 | 391.64M |
| March 31, 2023 | 276.49M |
| December 31, 2022 | 334.36M |
| September 30, 2022 | 324.25M |
| June 30, 2022 | 225.64M |
| March 31, 2022 | 209.14M |
| Date | Value |
|---|---|
| December 31, 2021 | 197.94M |
| September 30, 2021 | 229.70M |
| June 30, 2021 | 258.70M |
| March 31, 2021 | 251.23M |
| December 31, 2020 | 368.14M |
| September 30, 2020 | 281.23M |
| June 30, 2020 | 250.46M |
| March 31, 2020 | 115.39M |
| December 31, 2019 | 117.86M |
| September 30, 2019 | 125.16M |
| June 30, 2019 | 153.16M |
| March 31, 2019 | 170.57M |
| December 31, 2018 | 204.49M |
| September 30, 2018 | 122.95M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 22.02M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Upstream Bio, Inc. | 261.31M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |